FERRARINI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 161
EU - Europa 123
AS - Asia 53
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 347
Nazione #
US - Stati Uniti d'America 159
IT - Italia 38
SE - Svezia 38
CN - Cina 24
SG - Singapore 16
DE - Germania 14
BG - Bulgaria 12
GB - Regno Unito 8
VN - Vietnam 6
RU - Federazione Russa 5
CI - Costa d'Avorio 4
FI - Finlandia 4
FR - Francia 4
IN - India 4
SN - Senegal 4
TR - Turchia 3
CA - Canada 2
AU - Australia 1
EU - Europa 1
Totale 347
Città #
Woodbridge 20
Fairfield 19
Florence 17
Houston 14
Beijing 13
Sofia 12
Ashburn 10
Chandler 10
Anguillara Sabazia 8
London 8
Princeton 8
Seattle 8
Singapore 7
Wilmington 7
New York 6
Ann Arbor 5
Cambridge 5
Abidjan 4
Boardman 4
Dakar 4
Dong Ket 4
Düsseldorf 4
Lawrence 4
Marseille 4
Medford 4
Santa Clara 4
Grafing 3
Istanbul 3
Pisa 3
Fremont 2
Norwalk 2
Ottawa 2
San Diego 2
Shanghai 2
Changsha 1
Fuzhou 1
Guangzhou 1
Jiaxing 1
Jinan 1
Milan 1
Nanchang 1
Nanjing 1
Phoenix 1
Tappahannock 1
Wuhan 1
Totale 243
Nome #
Evaluation of safety and activity of everolimus plus exemestane in metastatic breast cancer: a single institution experience. 121
Incremental value of 3D echocardiography and two-dimensional speckle tracking in the early detection of cardiotoxicity linked to chemotherapy and trastuzumab in patients with HER-2 positive breast cancer 84
Inherited mutations in breast cancer susceptibility genes among a triple negative breast cancer color unselected for family history of breast cancer 80
T-DM1 for HER2 positive advanced breast cancer:a single institution, "real-life" experience. 75
Totale 360
Categoria #
all - tutte 1.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.130


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 6 4 4 3 5 4 10 0
2020/202126 1 1 0 4 0 2 0 1 5 4 1 7
2021/202257 0 0 0 1 12 12 0 4 5 2 3 18
2022/202376 13 20 8 0 0 5 1 5 18 0 6 0
2023/202432 3 3 4 0 6 7 4 0 1 0 0 4
2024/202522 0 4 3 11 4 0 0 0 0 0 0 0
Totale 360